Specify everything you need, do it as if you’re talking to your medical assistant,’ one dermatologist recommends.
Dr. Bhui challenges the myth of clinical neutrality, arguing that culture informs not only patients’ experiences of distress ...
In run-up to International Women's Day on 8 March, Dr Andrew Horne discussed what needs to be done in primary care to address ...
If these results are validated by prospective trials, it could become a valuable tool for oncologists to assess results ...
Internal medicine training (IMT) is the principal entry route to physician specialities in the UK.1 Yet, shortlisting metrics are drifting beyond what can reasonably be expected at this career stage.
Interview with Dimitrios Kontoyiannis, Professor and Robert C. Hickey Chair in Clinical ...
Vikram Talaulikar. Associate Specialist in Reproductive Medicine, University College London Hospitals NHS Foundation Trust; ...
Risant’s CEO Jaewon Ryu discusses some of the early success of bringing a set of Kaiser Permanente’s value-based care ...
Dr Bright Tato Forkuo, a medical officer, has expressed concerns over systemic challenges in Ghana's emergency healthcare ...
Dr Anthony Fletcher (Association of Black Cardiologists) shows how to improve representation, reduce mortality for men of color in cardiology ...
In an interview, C. Ola Landgren, MD, PhD, delved into the details of the FDA's draft guidance on using MRD as a basis for ...
Clinical Trials Arena on MSN
The clinical trial supply model of the future
With various challenges impacting the clinical supply chain, existing models are no longer fit-for-purpose and need to adapt.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results